1724452

Ziprasidone Related Compound D

United States Pharmacopeia (USP) Reference Standard

• 别名: 3-(1,2-Benzisothiazol-3-yl)-5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one, 3-(Benzo[d]isothiazol-3-yl)-5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one
• 经验公式（希尔记法）: C₂₈H₂₄ClN₅OS₂
• CAS号: 1159977-04-4
• 分子量: 546.11
• MDL编号: MFCD09259973
• UNSPSC代码: 41116107
• NACRES: NA.24

属性

• 等级: pharmaceutical primary standard
• API类: ziprasidone
• 制造商/商品名称: USP
• 应用: pharmaceutical (small molecule)
• 包装形式: neat
• 储存温度: 2-8°C
• InChI: 1S/C28H24ClN5OS2/c29-21-16-22-20(25(28(35)30-22)26-18-5-1-3-7-23(18)36-31-26)15-17(21)9-10-33-11-13-34(14-12-33)27-19-6-2-4-8-24(19)37-32-27/h1-8,15-16,25H,9-14H2,(H,30,35)
• InChI key: WMWHMDQKVMOIAL-UHFFFAOYSA-N

说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

分析说明

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

其他说明

Sales restrictions may apply.

安全信息

• 象形图: GHS08,GHS07
• 警示用语：: Warning
• 危险声明: H317,H373
• 预防措施声明: P260 - P272 - P280 - P302 + P352 - P314 - P333 + P313
• 危险分类: Skin Sens. 1 - STOT RE 2 Oral
• 靶器官: Liver,Central nervous system
• 储存分类代码: 11 - Combustible Solids
• WGK: WGK 3
• 闪点(°F): Not applicable
• 闪点(°C): Not applicable